| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 994277 | 57261 | PEROXIBEN 100 mg/g GEL | PEROXIBEN 100 mg/g GEL, 1 tubo de 60 g | 100 mg/g | 44 | 60 | 21 | 1 tubo de 60 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/57261/57261_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/57261/57261_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10266 | ISDIN S.A. | 1989-02-01 | 1 | 1 | 1 | 1989-02-01 | 1989-12-01 | 1 | 2011-09-01 | View Edit Delete | ||||||||||||
| 665559 | 57272 | IOPAMIRO 370 mg/ml SOLUCION INYECTABLE | IOPAMIRO 370 mg/ml SOLUCION INYECTABLE , 1 frasco de 500 ml | 370 mg/ml | 6 | 1 | 48 | 1 frasco de 500 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/57272/57272_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/57272/57272_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 9505 | LABORATORIOS FARMACEUTICOS ROVI S.A. | 1987-09-01 | 1 | 1 | 1 | 1987-09-01 | 2010-06-24 | 1 | 2013-06-28 | View Edit Delete | ||||||||||||
| 972950 | 57272 | IOPAMIRO 370 mg/ml SOLUCION INYECTABLE | IOPAMIRO 370 mg/ml SOLUCION INYECTABLE , 1 frasco de 100 ml | 370 mg/ml | 6 | 1 | 48 | 1 frasco de 100 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/57272/57272_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/57272/57272_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 9505 | LABORATORIOS FARMACEUTICOS ROVI S.A. | 1987-09-01 | 1 | 1 | 1 | 1987-09-01 | 1987-09-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 972976 | 57272 | IOPAMIRO 370 mg/ml SOLUCION INYECTABLE | IOPAMIRO 370 mg/ml SOLUCION INYECTABLE , 1 frasco de 50 ml | 370 mg/ml | 6 | 1 | 48 | 1 frasco de 50 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/57272/57272_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/57272/57272_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 9505 | LABORATORIOS FARMACEUTICOS ROVI S.A. | 1987-09-01 | 1 | 1 | 1 | 1987-09-01 | 1987-09-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 665558 | 57273 | IOPAMIRO 300 mg/ml SOLUCION INYECTABLE | IOPAMIRO 300 mg/ml SOLUCION INYECTABLE , 1 frasco de 500 ml | 300 mg/ml | 6 | 1 | 48 | 1 frasco de 500 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/57273/57273_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/57273/57273_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 9505 | LABORATORIOS FARMACEUTICOS ROVI S.A. | 1987-09-01 | 1 | 1 | 1 | 1987-09-01 | 2010-06-24 | 1 | 2013-06-24 | View Edit Delete | ||||||||||||
| 972984 | 57273 | IOPAMIRO 300 mg/ml SOLUCION INYECTABLE | IOPAMIRO 300 mg/ml SOLUCION INYECTABLE , 1 frasco de 100 ml | 300 mg/ml | 6 | 1 | 48 | 1 frasco de 100 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/57273/57273_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/57273/57273_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 9505 | LABORATORIOS FARMACEUTICOS ROVI S.A. | 1987-09-01 | 1 | 1 | 1 | 1987-09-01 | 1987-09-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 973008 | 57273 | IOPAMIRO 300 mg/ml SOLUCION INYECTABLE | IOPAMIRO 300 mg/ml SOLUCION INYECTABLE , 1 frasco de 50 ml | 300 mg/ml | 6 | 1 | 48 | 1 frasco de 50 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/57273/57273_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/57273/57273_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 9505 | LABORATORIOS FARMACEUTICOS ROVI S.A. | 1987-09-01 | 1 | 1 | 1 | 1987-09-01 | 1987-09-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 692077 | 57281 | RINGER LACTADO GRIFOLS SOLUCION PARA PERFUSION | RINGER LACTADO GRIFOLS SOLUCION PARA PERFUSION, 20 bolsas de 500 ml (FLEBOFLEX) | 6 mg/ml + 0,4 mg/ml + 0,2 mg/ml + 3,05 mg/ml inyectable 500 ml | 3 | 20 | 65 | 20 bolsas de 500 ml (FLEBOFLEX) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/57281/57281_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/57281/57281_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1234 | LABORATORIOS GRIFOLS S.A. | 1988-04-01 | 1 | 1 | 1 | 1988-04-01 | 2012-07-09 | 1 | 2013-03-22 | View Edit Delete | ||||||||||||
| 692078 | 57281 | RINGER LACTADO GRIFOLS SOLUCION PARA PERFUSION | RINGER LACTADO GRIFOLS SOLUCION PARA PERFUSION, 10 bolsas de 1.000 ml (FLEBOFLEX) | 6 mg/ml + 0,4 mg/ml + 0,2 mg/ml + 3,05 mg/ml inyectable 1.000 ml | 3 | 10 | 65 | 10 bolsas de 1.000 ml (FLEBOFLEX) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/57281/57281_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/57281/57281_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1234 | LABORATORIOS GRIFOLS S.A. | 1988-04-01 | 1 | 1 | 1 | 1988-04-01 | 2012-07-09 | 1 | 2013-03-22 | View Edit Delete | ||||||||||||
| 973388 | 57295 | BEMOLAN 800 mg GEL ORAL | BEMOLAN 800 mg GEL ORAL , 30 sobres | 800 mg | 35 | 30 | 64 | 30 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/57295/57295_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/57295/57295_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 70973 | TAKEDA FARMACEUTICA ESPANA S.A. | 1987-10-01 | 1 | 1 | 1 | 1987-10-01 | 1987-10-01 | 1 | 2011-09-13 | View Edit Delete | ||||||||||||
| 973495 | 57304 | CANESPIE BIFONAZOL 10 mg/ml SOLUCION PARA PULVERIZACION CUTANEA | CANESPIE BIFONAZOL 10 mg/ml SOLUCION PARA PULVERIZACION CUTANEA , 1 frasco de 30 ml | 10 mg/ml | 6 | 30 | 26 | 1 frasco de 30 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/57304/57304_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/57304/57304_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11424 | BAYER HISPANIA S.L. | 1987-06-01 | 1 | 1 | 1 | 1987-06-01 | 1987-06-01 | 1 | 2011-10-11 | View Edit Delete | ||||||||||||
| 973644 | 57311 | DURVITAN 300 mg CAPSULAS DURAS DE LIBERACION PROLONGADA | DURVITAN 300 mg CAPSULAS DURAS DE LIBERACION PROLONGADA, 10 cápsulas | 300 mg | 5 | 10 | 43 | 10 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/57311/57311_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/57311/57311_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10690 | ANOTACIONES FARMACEUTICAS, S.L. | 1989-02-01 | 1 | 1 | 1 | 1989-02-01 | 1989-02-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 974220 | 57356 | KYBERNIN P 500 UI, POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE O PERFUSION | KYBERNIN P 500 UI, POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE O PERFUSION, 1 vial + 1 vial de disolvente | 500 UI | 45 | 1 | 34 | 1 vial + 1 vial de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/57356/57356_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/57356/57356_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 37033 | CSL BEHRING S.A. | 1988-03-01 | 1 | 1 | 1 | 1988-03-01 | 1988-03-01 | 1 | 2019-08-30 | View Edit Delete | ||||||||||||
| 974238 | 57357 | KYBERNIN P 1000 UI, POLVO Y DISOLVENTE PARA SOLUCION PARA INYECCION O PERFUSION | KYBERNIN P 1000 UI, POLVO Y DISOLVENTE PARA SOLUCION PARA INYECCION O PERFUSION, 1 vial + 1 vial de disolvente | 1.000 UI | 45 | 1 | 34 | 1 vial + 1 vial de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/57357/57357_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/57357/57357_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 37033 | CSL BEHRING S.A. | 1988-03-01 | 1 | 1 | 1 | 1988-03-01 | 1988-03-01 | 1 | 2019-08-30 | View Edit Delete | ||||||||||||
| 974279 | 57359 | NITRODERM TTS 10 PARCHES TRANSDERMICOS | NITRODERM TTS 10 PARCHES TRANSDERMICOS , 30 parches | 10 mg/24 h | 74 | 30 | 28 | 30 parches | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/57359/57359_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/57359/57359_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 23616 | BEXAL FARMACEUTICA S.A. | 1987-07-01 | 1 | 1 | 1 | 1987-07-01 | 1987-07-01 | 0 | 2011-10-06 | View Edit Delete | ||||||||||||
| 974436 | 57369 | PEROXIBEN 25 mg/g GEL | PEROXIBEN 25 mg/g GEL, 1 tubo de 30 g | 25 mg/g | 44 | 30 | 21 | 1 tubo de 30 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/57369/57369_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/57369/57369_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10266 | ISDIN S.A. | 1989-02-01 | 1 | 1 | 1 | 1989-02-01 | 1989-02-01 | 1 | 2011-09-01 | View Edit Delete | ||||||||||||
| 974451 | 57371 | PEROXIBEN 50 mg/g GEL | PEROXIBEN 50 mg/g GEL, 1 tubo de 30 g | 50 mg/g | 44 | 30 | 21 | 1 tubo de 30 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/57371/57371_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/57371/57371_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10266 | ISDIN S.A. | 1989-02-01 | 1 | 1 | 1 | 1989-02-01 | 1989-02-01 | 1 | 2011-09-01 | View Edit Delete | ||||||||||||
| 994285 | 57371 | PEROXIBEN 50 mg/g GEL | PEROXIBEN 50 mg/g GEL, 1 tubo de 60 g | 50 mg/g | 44 | 60 | 21 | 1 tubo de 60 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/57371/57371_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/57371/57371_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10266 | ISDIN S.A. | 1989-02-01 | 1 | 1 | 1 | 1989-02-01 | 1989-02-01 | 1 | 2011-09-01 | View Edit Delete | ||||||||||||
| 974485 | 57373 | INISTON MUCOSIDAD Y CONGESTION 20 MG/ML + 6 MG/ML JARABE | INISTON MUCOSIDAD Y CONGESTION 20 MG/ML + 6 MG/ML JARABE , 1 frasco de 200 ml | 20 mg/ml + 6 mg/ml | 6 | 200 | 26 | 1 frasco de 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/57373/57373_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/57373/57373_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68780 | JNTL CONSUMER HEALTH (SPAIN) S.L. | 1988-01-01 | 1 | 1 | 1 | 1988-01-01 | 1988-01-01 | 1 | 2020-09-15 | View Edit Delete | ||||||||||||
| 636886 | 57391 | BARIGRAF AD 333,2 g POLVO PARA SUSPENSION ORAL | BARIGRAF AD 333,2 g POLVO PARA SUSPENSION ORAL , 10 envases unidosis de 340 g | 333,2 g | 6 | 10 | 17 | 10 envases unidosis de 340 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/57391/57391_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/57391/57391_p.pdf | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 945 | LABORATORIOS ERN S.A. | 1988-03-01 | 1 | 1 | 1 | 1988-03-01 | 1988-04-01 | 1 | 2011-02-08 | View Edit Delete |
Page 205 of 1035, showing 20 records out of 20697 total, starting on record 4081, ending on 4100